Infectious disease
EBV BRLF1 101-109 (HLA-A*29:02) IACPIVMRY
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP11142_1
Description
#
TechData
| Sequence: | IACPIVMRY |
| Gene: | BRLF1 |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Replication and transcription activator |
| UniProt Id: | P03209 |
| Species: | Epstein-Barr virus (EBV; Human herpesvirus 4) |
| Allele: | HLA-A*29:02 |
| Application: | Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
| Indication: | Infectious disease, Cancer, Neuroscience |
| Purity: | 95% HPLC-MS |
Skip product gallery
More EBV BRLF1 peptides
EBV BRLF-1 148-156 (HLA-A*03:01)
From
€105.00*
HLA-A*03:01-restricted epitope from Epstein-Barr Virus , EBV BRLF-1 (148-156). RVRAYTYSK is a linear peptidic epitope (epitope ID56390) studied as part of Replication and transcription activator from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
EBV BRLF1 134-142 (HLA-A*11:01)
€105.00*
Amount in mg:
1 mg
HLA-A11 restricted epitope from Epstein-Barr Virus BRLF1 (134-142) is a linear peptidic epitope (epitope ID 5002) studied as part of Replication and transcription activator from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assay
EBV BRLF1 28-37 (HLA-A*24:02)
From
€105.00*
Antigen Peptide EBV BRLF1 28-37 (HLA-A*24:02) DYCNVLNKEF for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.